COSYNE Trademark

Trademark Overview


On Friday, May 20, 2022, a trademark application was filed for COSYNE with the United States Patent and Trademark Office. The USPTO has given the COSYNE trademark a serial number of 97976494. The federal status of this trademark filing is REGISTERED as of Tuesday, November 14, 2023. This trademark is owned by CoSyne Therapeutics Limited. The COSYNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development
cosyne

General Information


Serial Number97976494
Word MarkCOSYNE
Filing DateFriday, May 20, 2022
Status700 - REGISTERED
Status DateTuesday, November 14, 2023
Registration Number7220288
Registration DateTuesday, November 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Pseudo MarkCOSINE
Goods and ServicesDrug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code042
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History


Party NameCoSyne Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Party NameCoSyne Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Party NameCoSyne Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Trademark Events


Event DateEvent Description
Tuesday, November 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 14, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 10, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 9, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, August 21, 2023USE AMENDMENT FILED
Tuesday, September 19, 2023DIVISIONAL PROCESSING COMPLETE
Monday, August 21, 2023DIVISIONAL REQUEST RECEIVED
Saturday, August 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 21, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, August 21, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022NEW APPLICATION ENTERED